Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Axsome Therapeutics Stock Forecast NASDAQ:AXSM
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-03 | 58.99% | Mizuho | $51.00 $49.00 | Maintains | Buy |
| 2022-04-27 | -12.39% | Morgan Stanley | $34.00 $27.00 | Maintains | Equal-Weight |
| 2022-03-29 | 149.84% | Jefferies | $71.00 $77.00 | Maintains | Buy |
| 2022-03-02 | 62.23% | SVB Leerink | $65.00 $50.00 | Maintains | Outperform |
| 2021-11-09 | 110.9% | SVB Leerink | $75.00 $65.00 | Maintains | Outperform |
| 2021-08-30 | 484.04% | HC Wainwright & Co. | $225.00 $180.00 | Maintains | Buy |
| 2021-08-10 | 419.14% | Truist Securities | $200.00 $160.00 | Maintains | Buy |
| 2021-08-10 | 10.32% | Morgan Stanley | $105.00 $34.00 | Downgrades | Overweight Equal-Weight |
| 2021-08-10 | 143.35% | SVB Leerink | $115.00 $75.00 | Maintains | Outperform |
| 2021-08-10 | 78.46% | Mizuho | $118.00 $55.00 | Maintains | Buy |
| 2021-06-10 | 263.4% | Berenberg | $112.00 | Initiates Coverage On | Buy |
| 2021-05-26 | 240.69% | Morgan Stanley | $104.00 $105.00 | Maintains | Overweight |
| 2021-04-27 | 630.05% | HC Wainwright & Co. | $210.00 $225.00 | Maintains | Buy |
| 2021-03-02 | 237.44% | Morgan Stanley | $101.00 $104.00 | Maintains | Overweight |
| 2021-01-08 | 318.56% | Jefferies | $129.00 | Initiates Coverage On | Buy |
| 2020-12-16 | 289.36% | Mizuho | $120.00 | Initiates Coverage On | Buy |
| 2020-11-09 | 227.71% | Morgan Stanley | $102.00 $101.00 | Maintains | Overweight |
| 2020-09-29 | 114.15% | B of A Securities | $66.00 | Initiates Coverage On | Underperform |
| 2020-09-10 | 230.95% | Morgan Stanley | $102.00 | Initiates Coverage On | Overweight |
| 2020-04-28 | 581.38% | HC Wainwright & Co. | $200.00 $210.00 | Maintains | Buy |
| 2020-04-28 | 325.05% | Cantor Fitzgerald | $125.00 $131.00 | Maintains | Overweight |
| 2020-04-14 | 208.24% | Cowen & Co. | $95.00 | Initiates Coverage On | Outperform |
| 2019-12-30 | 305.58% | Cantor Fitzgerald | $104.00 $125.00 | Reiterates | Overweight |
| 2019-12-30 | 548.93% | HC Wainwright & Co. | $170.00 $200.00 | Maintains | Buy |
| 2019-12-16 | 412.65% | Guggenheim | $65.00 $158.00 | Maintains | Buy |
| 2019-12-16 | 237.44% | Cantor Fitzgerald | $55.00 $104.00 | Maintains | Overweight |
| 2019-10-16 | 55.74% | Guggenheim | $48.00 | Initiates Coverage On | Buy |
| 2019-09-18 | - | William Blair | - | Initiates Coverage On | Outperform |
AXSM Stock Trend
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled.
Given the current short-term trend, the stock is expected to rise 7.81% during the next 3 months and, with a 90% probability hold a price between $27.44 and $52.16 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-18 | $25.52 | $36.98 | $48.44 |
| 2022-05-19 | $25.57 | $37.04 | $48.50 |
| 2022-05-20 | $25.63 | $37.10 | $48.56 |
| 2022-05-23 | $25.69 | $37.15 | $48.62 |
| 2022-05-24 | $25.75 | $37.21 | $48.68 |
| 2022-05-25 | $25.81 | $37.27 | $48.74 |
| 2022-05-26 | $25.87 | $37.33 | $48.79 |
| 2022-05-27 | $25.92 | $37.39 | $48.85 |
| 2022-05-31 | $25.98 | $37.45 | $48.91 |
| 2022-06-01 | $26.04 | $37.50 | $48.97 |
| 2022-06-02 | $26.10 | $37.56 | $49.03 |
| 2022-06-03 | $26.16 | $37.62 | $49.09 |
| 2022-06-06 | $26.22 | $37.68 | $49.14 |
| 2022-06-07 | $26.27 | $37.74 | $49.20 |
| 2022-06-08 | $26.33 | $37.80 | $49.26 |
| 2022-06-09 | $26.39 | $37.86 | $49.32 |
| 2022-06-10 | $26.45 | $37.91 | $49.38 |
| 2022-06-13 | $26.51 | $37.97 | $49.44 |
| 2022-06-14 | $26.57 | $38.03 | $49.49 |
| 2022-06-15 | $26.62 | $38.09 | $49.55 |
| 2022-06-16 | $26.68 | $38.15 | $49.61 |
| 2022-06-17 | $26.74 | $38.21 | $49.67 |
| 2022-06-21 | $26.80 | $38.26 | $49.73 |
| 2022-06-22 | $26.86 | $38.32 | $49.79 |
| 2022-06-23 | $26.92 | $38.38 | $49.84 |
| 2022-06-24 | $26.97 | $38.44 | $49.90 |
| 2022-06-27 | $27.03 | $38.50 | $49.96 |
| 2022-06-28 | $27.09 | $38.56 | $50.02 |
| 2022-06-29 | $27.15 | $38.61 | $50.08 |
| 2022-06-30 | $27.21 | $38.67 | $50.14 |
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of complex regional pain syndrome, knee osteoarthritis, and chronic low back pain; and AXS-05 that is in Phase III trial for the treatment of resistant depression and agitation in patients with Alzheimer's... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 108 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
